1. Home
  2. PFX vs MBOT Comparison

PFX vs MBOT Comparison

Compare PFX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

N/A

Current Price

$42.03

Market Cap

86.7M

Sector

Finance

ML Signal

N/A

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

N/A

Current Price

$1.11

Market Cap

73.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PFX
MBOT
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.7M
73.2M
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
PFX
MBOT
Price
$42.03
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.38
AVG Volume (30 Days)
819.0
★ 745.1K
Earning Date
12-11-2026
11-20-2026
Dividend Yield
★ 3.46%
N/A
EPS Growth
N/A
★ 60.27
EPS
★ 0.30
N/A
Revenue
N/A
★ $116,887.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$377.83
P/E Ratio
$144.98
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.30
$0.93
52 Week High
$56.48
$2.86

Technical Indicators

Market Signals
Indicator
PFX
MBOT
Relative Strength Index (RSI) 43.35 49.23
Support Level $41.86 N/A
Resistance Level $42.54 $2.00
Average True Range (ATR) 0.17 0.07
MACD -0.02 0.03
Stochastic Oscillator 57.13 64.00

Price Performance

Historical Comparison
PFX
MBOT

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: